Edition:
United States

People: Pfizer Inc (PFE)

PFE on New York Consolidated

35.08USD
25 Aug 2016
Change (% chg)

$0.26 (+0.75%)
Prev Close
$34.82
Open
$34.76
Day's High
$35.19
Day's Low
$34.66
Volume
8,245,878
Avg. Vol
24,450,392
52-wk High
$37.39
52-wk Low
$28.25

Read, Ian 

Mr. Ian C. Read is Chairman of the Board, Chief Executive Officer of the Company. He served as Senior Vice President and Group President of the Worldwide Biopharmaceutical Businesses, which he led from 2006 through December 2010. In that role, he oversaw five global business units—Primary Care, Specialty Care, Oncology, Established Products and Emerging Markets. Mr. Read began his career with Pfizer in 1978 as an operational auditor. He worked in Latin America through 1995, holding positions including Chief Financial Officer, Pfizer Mexico, and Country Manager, Pfizer Brazil. In 1996, he was appointed President of Pfizer’s International Pharmaceuticals Group, with responsibility for Latin America and Canada. He became Executive Vice President, Europe, in 2000, was named a Corporate Vice President in 2001, and assumed responsibility for Canada, in addition to Europe, in 2002. Mr. Read later became accountable for operations in both the Africa/Middle East region and Latin America as well. Director of Kimberly-Clark Corporation. Mr. Read serves on the Boards of Pharmaceutical Research and Manufacturers of America (PhRMA) and the Partnership of New York City. He is member of the U.S.-China Business Council.

Basic Compensation

Total Annual Compensation, USD 6,158,750
Restricted Stock Awards, USD 2,011,630
Long-Term Incentive Plans, USD --
All Other, USD 9,817,580
Fiscal Year Total, USD 17,988,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 338,000 1,474,750.00
Name Fiscal Year Total

Ian Read

17,988,000

Frank D'Amelio

6,670,170

Albert Bourla

--

Mikael Dolsten

6,057,870

John Young

5,918,920

Rady Johnson

--
As Of  30 Dec 2015